Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027, or upon successor appointment

PUBT · 2d ago
Jazz Pharmaceuticals CCO Samantha Pearce to retire by June 30, 2027, or upon successor appointment
  • Jazz Pharmaceuticals EVP and Chief Commercial Officer Samantha Pearce notified the company she plans to retire from the role.
  • Retirement set for the earlier of a successor’s appointment or June 30, 2027.
  • A formal search process is set to begin, spanning internal and external candidates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065497), on October 09, 2026, and is solely responsible for the information contained therein.